JPMorgan Chase & Co. raised its stake in HealthStream, Inc. (NASDAQ:HSTM – Free Report) by 18.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 57,204 shares of the technology company’s stock after buying an additional 9,017 shares during the period. JPMorgan Chase & Co. owned about 0.19% of HealthStream worth $1,650,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently added to or reduced their stakes in HSTM. Harbor Capital Advisors Inc. boosted its position in HealthStream by 141.2% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 400,033 shares of the technology company’s stock valued at $11,537,000 after buying an additional 234,148 shares during the period. Polar Asset Management Partners Inc. purchased a new stake in HealthStream in the 3rd quarter valued at about $1,635,000. Assenagon Asset Management S.A. boosted its position in HealthStream by 37.3% in the 3rd quarter. Assenagon Asset Management S.A. now owns 201,601 shares of the technology company’s stock valued at $5,814,000 after buying an additional 54,775 shares during the period. Barclays PLC boosted its position in HealthStream by 145.0% in the 3rd quarter. Barclays PLC now owns 58,838 shares of the technology company’s stock valued at $1,697,000 after buying an additional 34,821 shares during the period. Finally, AQR Capital Management LLC boosted its position in HealthStream by 32.4% in the 2nd quarter. AQR Capital Management LLC now owns 128,036 shares of the technology company’s stock valued at $3,572,000 after buying an additional 31,314 shares during the period. 69.58% of the stock is owned by hedge funds and other institutional investors.
HealthStream Stock Performance
NASDAQ:HSTM opened at $32.06 on Thursday. HealthStream, Inc. has a one year low of $23.92 and a one year high of $33.52. The firm has a market cap of $975.27 million, a P/E ratio of 49.32, a P/E/G ratio of 4.15 and a beta of 0.40. The firm has a 50-day simple moving average of $32.06 and a 200-day simple moving average of $30.08.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on HSTM shares. Barclays boosted their price objective on shares of HealthStream from $32.00 to $34.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Craig Hallum upgraded shares of HealthStream to a “strong-buy” rating in a report on Thursday, October 17th. Finally, Canaccord Genuity Group boosted their price target on shares of HealthStream from $28.00 to $29.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, HealthStream has a consensus rating of “Buy” and a consensus target price of $31.50.
View Our Latest Analysis on HSTM
HealthStream Company Profile
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
Recommended Stories
- Five stocks we like better than HealthStream
- What to Know About Investing in Penny Stocks
- Oracle Announces Game-Changing News for the AI Industry
- Stock Market Upgrades: What Are They?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.